Quantcast
Home / Practice Areas / Business and Civil Practice / Justices to rule on preemption of drug design defect claims

Justices to rule on preemption of drug design defect claims

The U.S. Supreme Court has agreed to decide whether federal law preempts state law design defect claims targeting generic pharmaceutical products.
Scroll To Top